MINDY QUAINTANCE: Open Payments
NPI 1225652902 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 26 payments from 8 companies in 2025. Trend: 2023 $560 · 2024 $514 · 2025 $459
Food & beverage: $459
| Company | Payments | Amount |
|---|---|---|
| Exeltis, USA Inc. | 5 | $103 |
| Sumitomo Pharma America, Inc. | 5 | $85 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $74 |
| Astellas Pharma US Inc | 4 | $74 |
| Organon LLC | 2 | $40 |
| MILLICENT US INC | 2 | $35 |
| Evofem Biosciences, Inc. | 2 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
Products named: SLYND, Veozah, MYFEMBREE, NEXPLANON, Phexxi, INTRAROSA, Mirena, GEMTESA.
Industry payments across LA — which companies pay providers there.
